Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue April 2015
 •  Analysts Poke Holes in Lafley's Strategy  •  Estee Lauder Taps Eva Mendes  •  Scent Trends for 2016  •  Dollar Derails P&G  •  StriVectin Partners with mySkin Inc.
Print

End-User Markets - Skin Care


Refine by Date:
From: To:
Meeting Point
By Christine Esposito, Associate Editor
Published June 9, 2014
Hair care and skin care collide at the scalp. Here’s a look at three new products that are paying closer attention to this special area. Read More »
Amway Starts Up
In Bulgaria
Published June 6, 2014
Nutrilite, Artistry and more in Eastern Europe. Read More »
Sunstar Brings Equitance To US Market
Published June 5, 2014
New skin care line combines topicals with dietary supplement. Read More »
Burned by BurnLounge?
Published June 4, 2014
Herbalife says court ruling is a win for MLM. Read More »
TSG Sells Stake in Perricone MD
Published June 4, 2014
Dermatologist developed line lands at Lion Capital. Read More »
Artistry Rolls Out Brightening Collection
Published June 4, 2014
New 7-SKU Ideal Radiance line takes "holistic" approach. Read More »
Givaudan Completes Soliance Acquisition
Published June 3, 2014
Strengthens process development and research capabilities. Read More »
AS Watson To Sell Travel Unit
Published June 3, 2014
Move enables retailer to focus on cosmetics. Read More »
Ding-Dong!
Avon Stalling
Published June 2, 2014
With turnaround slowing, sale talk resumes. Read More »
The Honest Co. at Target
Published May 30, 2014
Select SKUs in all stores, with expanded offerings coming June 15. Read More »
Incorporating Genomics into Skin Care Development
Published May 29, 2014
Anna Langerveld, CEO, Genemarkers, explains how it works. Read More »
NeoStrata Goes For Three
Published May 29, 2014
Exuviance Triple Microdermabrasion available in August. Read More »
Med Device Firm Eyes Consumer Market
Published May 29, 2014
Eternity Healthcare explores at-home hair removal category. Read More »
Nestle Expands Skin Health Platform
Published May 28, 2014
To purchase key assets of Valeant Pharmaceutical for $1.4 billion. Read More »
Fibig Replaces Tough
As CEO at IFF
Published May 28, 2014
Move is effective Sept. 1, 2014. Read More »